0001567619-21-016263.txt : 20210824
0001567619-21-016263.hdr.sgml : 20210824
20210824115054
ACCESSION NUMBER: 0001567619-21-016263
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210819
FILED AS OF DATE: 20210824
DATE AS OF CHANGE: 20210824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhen Marianne
CENTRAL INDEX KEY: 0001750085
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 211200481
MAIL ADDRESS:
STREET 1: C/O INNOVIVA, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2021-08-19
2021-08-23
0
0001080014
Innoviva, Inc.
INVA
0001750085
Zhen Marianne
1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME
CA
94010
0
1
0
0
Chief Accounting Officer
Common Stock
2021-08-20
4
S
0
1129
15.89
D
35364
D
The Form 4 of the Reporting Person filed with the Securities and Exchange Commission on August 23, 2021 inadvertently indicated in Column 4 of Table I that the sale by the Reporting Person of 1,129 shares of Common Stock of the Issuer on August 20, 2021 was an acquisition "(A)" rather than a disposition "(D)". For the avoidance of doubt, such sale transaction was a disposition "(D)".
/s/ Marianne Zhen
2021-08-24